Home › NDC Lookup › RxCUI directory › RxCUI 1490671

Triprolidine hydrochloride 0.5 MG/ML Oral Solution — RxCUI 1490671

RxNorm drug concept · Semantic clinical drug
RxCUI 1490671 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1490671
Official nameTriprolidine hydrochloride 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astriprolidine hydrochloride 2.5 MG per 5 ML Oral Solution; triprolidine HCl 2.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)8,160 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triprolidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Triprolidine helps relieve the common, uncomfortable symptoms of hay fever and other upper respiratory allergies — things like a runny nose, sneezing, itchy or watery eyes, and itc...
  • Yes, drowsiness is a real possibility with triprolidine, and it's something to take seriously. Avoid driving, operating machinery, or doing anything that needs sharp focus until yo...
  • For children under 6 years old, you should check with a doctor before giving any triprolidine product. The labels for these products don't include dosing for that age group without...
  • Yes — if you have emphysema, chronic bronchitis, glaucoma, or trouble urinating due to an enlarged prostate, you should not take triprolidine without talking to a doctor first. The...
📖 Read our full Triprolidine guide →

🕸️ Concept Web — How Triprolidine hydrochloride 0.5 MG/ML Oral Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Triprolidine hydrochloride 0.5 MG/ML Oral Solution RxCUI 1490671

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Triprolidine 10849
    • Triprolidine hydrochloride 71534
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Triprolidine Oral Solution 376317
    • Triprolidine hydrochloride Oral Solution 2647555
    • Triprolidine Oral Liquid Product 1159349
    • Triprolidine Oral Product 1159350
    • Triprolidine hydrochloride Oral Liquid Product 2659962
    • Triprolidine hydrochloride Oral Product 2661554
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Triprolidine hydrochloride 0.5 MG/ML 1094403

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Triprolidine hydrochloride 0.5 MG/ML SCDC · 1094403
  • Triprolidine Oral Solution SCDF · 376317
  • Triprolidine hydrochloride Oral Solution SCDFP · 2647555
  • Triprolidine Oral Liquid Product SCDG · 1159349
  • Triprolidine Oral Product SCDG · 1159350
  • Triprolidine hydrochloride Oral Liquid Product SCDGP · 2659962
  • Triprolidine hydrochloride Oral Product SCDGP · 2661554

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1490671 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
28595-0802-08 237 mL in 1 BOTTLE (28595-802-08) HISTEX Allegis Pharmaceuticals, LLC 2014-03-04
Observed labelers: Allegis Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1011
Range $0.1011–$0.1011 · middle 50% $0.1011–$0.1011 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.